MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study

David S. Hong, David Hui, Éduardo Bruera, Filip Jankú, Aung Naing, Gerald S. Falchook, Sarina A. Piha‐Paul, Jennifer J. Wheler, Siqing Fu, Apostolia M. Tsimberidou,

The Lancet Oncology · 2014 · 192 citations · 34 references

Concepts

References

34